According to the results of a study released on Monday, the Company and their German partner BioNTech say that they gave children aged five to 11 years, a two-dose regimen of 10 μg (micrograms) which were administered 21 days apart. The dosage was selected as the preferred dose for safety and effectiveness in children.
IP: 220.127.116.11. Referrer: . FirstClickFree: 0. Clicks by IP: ?. Clicks by cookie: ?.